Series B · Healthtech · London, United Kingdom · Founded 2018 · 201–500 employees
Voy, originally founded as Manual, is a clinical digital health platform providing personalized, vertically integrated care for chronic and life-impacting conditions. The platform integrates remote medical diagnoses, custom habit-coaching, and prescription GLP-1 weight-loss medications into a unified digital subscription model. To fuel its growth, the company secured a significant £29 million Series B equity round in September 2024. This was subsequently bolstered in November 2025 by a $120 million non-dilutive Customer Value Fund facility from General Catalyst.
No open roles listed right now.